MedTrace Logo

CO2 Clearance During Noninvasive Ventilation (NIV)

NCT03756415 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-11-28

No results posted yet for this study

Summary

In this randomized cross over study the investigators will evaluate the effects on gas exchange and patients' tolerance of a new CO2 non rebreathing devices incorporated in the mask vs the traditional mask COPD patients undergoing NIV for an episode of Acute Hypercapnia Respiratory Failure, will be randomized after at least 12 hour of ventilation to 1 h.trial with the usual full face mask or the same mask with the addition of a new CO2 clearance device

Conditions

  • Acute Hypercapnic Respiratory Failure

Interventions

DEVICE

DiMax Zero Total face mask "R",

a non-CO2 rebreathing device included directly in the full face mask

DEVICE

traditional face mask

a traditional mask without a non-CO2 rebreathing device included directly in the full face mask

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • stefano nava · Azienda Ospedaliera Sant'Orsola

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-06-01
Completion
2019-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03756415 on ClinicalTrials.gov